Journal
JOURNAL OF IMMUNOLOGY
Volume 179, Issue 4, Pages 2261-2269Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.179.4.2261
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI-64128, AI50831] Funding Source: Medline
- NIGMS NIH HHS [GM41514, GM-48071] Funding Source: Medline
Ask authors/readers for more resources
Recruitment of PI3K to the cell membrane is an indispensable step in normal lymphocyte proliferation and activation. In this study we identify PI3K as an important signaling molecule for maintaining basal T and B lymphocyte motility and homing in the intact lymph node. Pharmacological inhibition of PI3K catalytic isoforms exerted broad effects on basal lymphocyte motility, including changes in homing kinetics, localization of B cells within the lymph node, and reduced cell velocities. Lymphocytes deficient in either or both of the class IA PI3K regulatory subunits p85 alpha and p85 beta also exhibited reduced velocities, with the magnitude of reduction depending upon both cell type and isoforin specificity. B cells deficient in p85 alpha exhibited gross morphological abnormalities that were not evident in cells treated with a PI3K inhibitor. Our results show, for the first time, that class IA PI3Ks play an important role in regulating basal lymphocyte motility and that p85 alpha regulatory subunit expression is required to maintain B cell morphology in a manner independent of PI3K catalytic function. Moreover, we demonstrate distinct roles for catalytic domain function and class IA PI3K regulatory domain activity in lymphocyte motility, homing, and homeostatic localization of mature resting B cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available